TD Ameritrade Investment Management’s DexCom DXCM Stock Holding History

TD Ameritrade Investment Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-24	Closed	-$3K	–	125
2023 Q2	$3K	Sell	24 -9	-27%	-$1.09K	﹤0.01%	426
2023 Q1	$4K	Hold	33	–	–	﹤0.01%	434
2022 Q4	$4K	Buy	33 +13	+65%	+$1.43K	﹤0.01%	440
2022 Q3	$2K	Sell	20 -17	-46%	-$1.44K	﹤0.01%	499
2022 Q2	$3K	Sell	37 -7	-16%	-$639	﹤0.01%	504
2022 Q1	$6K	Hold	44	–	–	﹤0.01%	528
2021 Q4	$6K	Buy	+44	New	+$6.32K	﹤0.01%	517
2021 Q3	–	Sell	-20	Closed	-$2K	–	661
2021 Q2	$2K	Buy	+20	New	+$1.92K	﹤0.01%	592
2019 Q2	–	Sell	-408	Closed	-$12K	–	649
2019 Q1	$12K	Buy	408 +364	+827%	+$12.8K	﹤0.01%	331
2018 Q4	$1K	Buy	+44	New	+$1.4K	﹤0.01%	557

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

TD Ameritrade Investment Management's DXCM Position: Q3 2023 in Review

TD Ameritrade Investment Management sold out of DexCom (DXCM) in Q3 2023, closing a stake of 24 shares — an estimated $3K sold.

TD Ameritrade Investment Management first reported a position in DXCM in Q4 2018 and held it in 10 quarters. The position peaked at $12K in Q1 2019. 903 funds tracked by Wall St. Rank hold DXCM as of Q3 2023.

TD Ameritrade Investment Management reported no remaining DexCom position as of Q3 2023 after selling out during the quarter.
TD Ameritrade Investment Management sold 24 DexCom shares in Q3 2023, an estimated $3K.
TD Ameritrade Investment Management first reported a position in DexCom in Q4 2018 and held it in 10 quarters.
TD Ameritrade Investment Management's DexCom position peaked at $12K in Q1 2019.
903 funds tracked by Wall St. Rank held DexCom as of Q3 2023.

Based on TD Ameritrade Investment Management's 13F filing for Q3 2023.